Chen, Jui-YiJui-YiChenPan, Heng-ChihHeng-ChihPanShiao, Chih-ChungChih-ChungShiaoChuang, Min-HsiangMin-HsiangChuangSee, Chun YinChun YinSeeYeh, Tzu-HsuanTzu-HsuanYehYang, YafeiYafeiYangChu, Wen-KaiWen-KaiChuVIN-CENT WU2023-12-082023-12-082023-10-271475-2840https://scholars.lib.ntu.edu.tw/handle/123456789/637614A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM), heart failure (HF), and chronic kidney disease (CKD) has not been previously conducted.enChronic kidney disease; Diabetes; Heart failure; Network meta-analysis; SGLT2 inhibitor[SDGs]SDG3journal article10.1186/s12933-023-02035-8378915502-s2.0-85174894081https://api.elsevier.com/content/abstract/scopus_id/85174894081